ABP
Price
$1.10
Change
-$0.13 (-10.57%)
Updated
Dec 18, 04:59 PM (EDT)
PVLA
Price
$11.81
Change
-$1.19 (-9.15%)
Updated
Dec 18, 04:55 PM (EDT)
Ad is loading...

ABP vs PVLA

Header iconABP vs PVLA Comparison
Open Charts ABP vs PVLABanner chart's image
Abpro Holdings
Price$1.10
Change-$0.13 (-10.57%)
Volume$300
CapitalizationN/A
Palvella Therapeutics
Price$11.81
Change-$1.19 (-9.15%)
Volume$200
CapitalizationN/A
ABP vs PVLA Comparison Chart
Loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABP vs. PVLA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a Hold and PVLA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ABP: $1.23 vs. PVLA: $13.00)
Brand notoriety: ABP and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 18% vs. PVLA: 504%
Market capitalization -- ABP: $63.37M vs. PVLA: $145.88M
ABP [@Biotechnology] is valued at $63.37M. PVLA’s [@Biotechnology] market capitalization is $145.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 0 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • ABP’s FA Score: 0 green, 5 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, PVLA is a better buy in the long-term than ABP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 3 TA indicator(s) are bullish while PVLA’s TA Score has 3 bullish TA indicator(s).

  • ABP’s TA Score: 3 bullish, 1 bearish.
  • PVLA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ABP is a better buy in the short-term than PVLA.

Price Growth

ABP (@Biotechnology) experienced а -30.90% price change this week, while PVLA (@Biotechnology) price change was -23.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($132M) has a higher market cap than ABP($63.4M). PVLA YTD gains are higher at: 7042.857 vs. ABP (-88.374).
ABPPVLAABP / PVLA
Capitalization63.4M132M48%
EBITDAN/AN/A-
Gain YTD-88.3747042.857-1%
P/E RatioN/A5.99-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PVLA: Fundamental Ratings
PVLA
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABPPVLA
RSI
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
39%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
10%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
13%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
18%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMCIX17.03N/A
N/A
RBC SMID Cap Growth I
LMOFX39.93-0.19
-0.47%
Patient Opportunity FI
HLPPX11.47-0.06
-0.52%
LDR Real Estate Value Opportunity P
RPMAX17.23-0.15
-0.86%
Reinhart Genesis PMV Investor
OEGCX20.20-0.28
-1.37%
Invesco Discovery Mid Cap Growth C

ABP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABP has been loosely correlated with NGNE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ABP jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
-3.91%
NGNE - ABP
45%
Loosely correlated
-5.61%
SNDX - ABP
37%
Loosely correlated
-1.16%
PHAT - ABP
35%
Loosely correlated
+2.83%
TFFP - ABP
27%
Poorly correlated
N/A
ABOS - ABP
24%
Poorly correlated
-0.51%
More

PVLA and

Correlation & Price change

A.I.dvisor tells us that PVLA and ABVC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PVLA and ABVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+1.33%
ABVC - PVLA
26%
Poorly correlated
-5.59%
PIRS - PVLA
23%
Poorly correlated
N/A
KPRX - PVLA
20%
Poorly correlated
-3.06%
ABP - PVLA
2%
Poorly correlated
-3.91%
ACOG - PVLA
-1%
Poorly correlated
+16.49%
More